Mass General Brigham Launches Genetic Test for Eight Cardiovascular Conditions
The clinician-ordered test integrates polygenic risk scores validated in over 236,000 participants from the NIH's All of Us Research Program.
Latest Articles
Editor's Top Picks
Clinical Labs Navigate What’s Next After FDA’s LDT Rule Reversal
Greer Massey, PhD, chief scientific officer at Molecular Designs, shares insights on how labs are affected by the rule’s reversal and how they can prepare for future regulatory changes.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
UAE Approves Biomerica’s Home Kidney Test
The test detects early albumin markers in urine within 10 minutes, targeting high-risk diabetes and hypertension patients.
Equipment & Supply Spotlight
Multitiered Business Intelligence Platform for Lab Data Analytics Launches
The new platform offers three-tiered approach to help laboratories at different stages of data maturity extract actionable insights from operational data.
News, Know-How & Standards
Disease Detection & Understanding
Genomic Test Shows Promise for Guiding Chemotherapy Decisions in Metastatic Prostate Cancer
Phase 3 STAMPEDE trial data demonstrates Decipher Prostate test can predict docetaxel treatment benefit, potentially helping patients avoid unnecessary toxicity.
